BioSante Pharmaceuticals Announces New LibiGel(R) Phase III Efficacy Trials

BioSante Pharmaceuticals Announces New LibiGel(R) Phase III Efficacy Trials

LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). Two Phase III efficacy trials of LibiGel have been …
See all stories on this topic »

Guantanamo Connection? Documents Show CIA Stockpiled Antimalaria Drugs as …

In June 2004, the CDC announced, “‘presumptive treatment’ without the benefit of laboratory confirmation should be reserved for extreme circumstances (strong clinical suspicion, severe disease, impossibility of obtaining prompt laboratory confirmation) …
See all stories on this topic »

Medidata Solutions To Lead Discussions On Cloud-based Clinical Technology At …

“Attendees of Medidata-led sessions and visitors to our booth will be shown real-world examples of how leveraging the clinical cloud can help increase efficiencies while reducing cost and risk from clinical trial concept to conclusion.
See all stories on this topic »

Coulter brace helps clinical Armagh sink Wee County

It was tough on Louth, who lost to London in last year’s final, and Pat Clancy’s side were put to the sword in the first half by the clinical Ulstermen, who secured their second title in three seasons. Declan Coulter bagged two goals in the opening …
See all stories on this topic »

Tengion Announces Continued Clinical Progress on Key Milestones for Neo …

WINSTON-SALEM, NC, June 11, 2012 /PRNewswire via COMTEX/ — Tengion, Inc. (NASDAQ:TNGN) , a leader in regenerative medicine, today announced continued clinical progress on key milestones for the ongoing Phase 1 trial of the Company’s most advanced …
See all stories on this topic »

Contract research news in brief

A round-up of news in the contract research services sector, including updates from Foundation Medicine, Complete Genomics, eResearch Technology, LabCorp and ERA Clinical. Novartis has extended a collaboration with cancer diagnostics specialist …
See all stories on this topic »

ReVision Optics Advances PresbyLens into Phase 3 Clinical Trial for Improving …

The Phase 3 clinical trial will evaluate the safety and effectiveness of the PresbyLens in improving near vision in subjects with presbyopia. In this prospective, multicenter trial, subjects will be implanted with the PresbyLens in their non-dominant …
See all stories on this topic »

Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial

BEIJING, June 11, 2012 /PRNewswire via COMTEX/ — Sinovac Biotech Ltd. (NASDAQ:SVA) , a leading provider of biopharmaceutical products in China, today announced a positive SFDA inspection of the three clinical trial sites being used in the Company’s …
See all stories on this topic »

Business People in the News

Theorem Clinical Research, a King of Prussia contract research organization that provides core clinical research and development services, hired Brian Mooney as senior vice president of global clinical development. He had been senior vice president of …
See all stories on this topic »

Rachna Mehra Discusses Clinical Trials of Platelet Rich Plasma Adult Stem Cell …

The Data Safety Monitoring Board (DSMB) has recommended that the trial be expanded from its current three clinical sites to a total of 15 clinical sites. Dr. Rachna Mehra, who specializes in adult stem cell treatment, believes that the successes …
See all stories on this topic »

**********************
MORE USEFUL INFORMATION....
The LINKS below are from high authority and related sites.
You might also find them useful. Thanks for visiting !


BioSante Pharmaceuticals Announces New LibiGel(R) Phase III Efficacy Trials
BioSante Pharmaceuticals Announces New LibiGel(R) Phase III Efficacy Trials
Clinical Center News
NIMH » Science News about Clinical Research and Trials

Incoming search engine referrals:

• libigel drug name